Literature DB >> 4402011

Pindolol, (Visken, LB46). A new treatment for hypertension: report of a multicentric open study.

I S Collins, I W King.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4402011

Source DB:  PubMed          Journal:  Curr Ther Res Clin Exp        ISSN: 0011-393X


× No keyword cloud information.
  11 in total

Review 1.  Side effects and contraindications of beta-receptor blocking agents.

Authors:  H Lydtin
Journal:  Klin Wochenschr       Date:  1977-05-01

2.  Decrease in plasma noradrenaline levels following long-term treatment with prindolol in patients with essential hypertension.

Authors:  H M Brecht; F Banthien; W Schoeppe
Journal:  Klin Wochenschr       Date:  1976-11-15

Review 3.  The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.

Authors:  B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

4.  The effect of the beta-adrenoceptor antagonist pindolol on exercise performance.

Authors:  R C Dhatariya; A J Blowers
Journal:  Br J Clin Pharmacol       Date:  1982-05       Impact factor: 4.335

Review 5.  Adverse effects of antihypertensive drugs.

Authors:  F E Husserl; F H Messerli
Journal:  Drugs       Date:  1981-09       Impact factor: 9.546

Review 6.  Adverse reactions to beta-adrenergic receptor blocking drugs: a report from the Boston collaborative drug surveillance program.

Authors:  D J Greenblatt; J Koch-Weser
Journal:  Drugs       Date:  1974       Impact factor: 9.546

Review 7.  Beta-adrenergic receptor blocking drugs in hypertension.

Authors:  F O Simpson
Journal:  Drugs       Date:  1974       Impact factor: 9.546

8.  Studies on the cardiovascular effects of pindolol in DOCA/saline hypertensive rats.

Authors:  R E Buckingham; T C Hamilton; D Robson
Journal:  Br J Pharmacol       Date:  1977-07       Impact factor: 8.739

9.  Hypotensive effect of oxprenolol in mild to moderate hypertension: a multicentre controlled study.

Authors:  M Motolese; G Muiesan; A Colombi
Journal:  Eur J Clin Pharmacol       Date:  1975       Impact factor: 2.953

10.  Comparison of methods to detect side-effect on clinical application of chloranolol, a beta-adrenergic receptor inhibitor.

Authors:  E Török; E Kósa; M Szontagh; P Juvancz; J Eggenhofer; J Borvendég
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.